Oklahoma Takes on Big Pharma in First Major Opioid Trial

Oklahoma’s bellwether trial over the opioid crisis began Tuesday with officials accusing pharmaceutical giant Johnson & Johnson of acting as a “drug kingpin” that killed over 4,600 Oklahomans through unintentional overdoses and created a public nuisance that cost the state billions of dollars.

Read more

Opioids

Insys Therapeutics and its former vice president of sales Alec Burlakoff will pay $9.5 million to settle claims that they paid doctors lucrative “speaker fees” in exchange for the doctors writing prescriptions for Insys’ flagship drug, Subsys, “a fentanyl drug,” the Arizona attorney general said.

Read more

Judge Dismisses Shareholder Action Over Pharma Company’s Marketing of Opioid Treatment Drug

(CN) – A New York District judge granted pharmaceutical company Alkermes PLC’s motion to dismiss a shareholder class action alleging the company misrepresented sales figures and comparative effectiveness for a drug developed to treat opioid dependence.

Read more